Vivo Opportunity Fund Holdings, L.P. - 30 Sep 2025 SCHEDULE 13G Report for Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share (CMPX)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
CMPX
Shares outstanding
176,391,745 shares
Disclosed Ownership
8,995,979 shares
Ownership
5.1%
Form type
SCHEDULE 13G
Filing time
14 Nov 2025, 18:35:56 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Vivo Opportunity Fund Holdings, L.P. disclosed 5.1% ownership in Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share (CMPX) on 30 Sep 2025."

Quick Takeaways

  • Vivo Opportunity Fund Holdings, L.P. filed SCHEDULE 13G for Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share (CMPX).
  • Disclosed ownership: 5.1%.
  • Date of event: 30 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Nov 2025, 18:35.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 5.1% 8,995,979 8,995,979 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity, LLC 5.1% 8,995,979 8,995,979 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman Fund, L.P. 0.3% 549,487 549,487 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity Cayman, LLC, General Partner
Vivo Opportunity Cayman, LLC 0.3% 549,487 549,487 0 /s/ Kevin Dai Kevin Dai/Managing Member

Sponsored